Process Industries · Chemicals: Agricultural · NSE: ASTEC · data 2026-10-09

Astec Lifesciences Limited

Health check: Weak (1.9/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹729.3

Market cap

₹1,592 cr

P/E

—

P/B

—

ROE

-25.9%

ROCE

-9.8%

Debt / equity

1.15

Dividend yield

0.00%

1-year return

-6.9%

52-week high

₹941.75

52-week low

₹513.4

Operating margin

-8.8%

Growth

Revenue (last 12 months)	₹441 cr
Net profit (last 12 months)	₹-67 cr
Sales growth, 3 years (yearly)	-10.7%
Profit growth, 3 years (yearly)	—

Similar companies

Kothari Industrial Corp. Ltd. (KOTIC) · Insecticides (India) Limited (INSECTICID) · Bharat Rasayan Limited (BHARATRAS) · India Pesticides Ltd. (IPL) · 3B BlackBio Dx Ltd (3BBLACKBIO)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open ASTEC in NSE Scanner →